首页> 外文期刊>Nephrology. >A case of IgG4-positive plasma cell-rich tubulointerstitial nephritis in a kidney allograft mimicking IgG4-related kidney disease
【24h】

A case of IgG4-positive plasma cell-rich tubulointerstitial nephritis in a kidney allograft mimicking IgG4-related kidney disease

机译:模仿IgG4相关肾脏疾病的同种异体肾移植中IgG4阳性浆细胞丰富的肾小管间质性肾炎1例

获取原文
获取原文并翻译 | 示例
       

摘要

A 51-year-old woman received an ABO blood type-incompatible renal transplant. She was administered rituximab and basiliximab and underwent plasma exchanges for induction therapy, followed by administration of tacrolimus, mycophenolate mofetil and methylprednisolone as maintenance immunosupression therapy. A planned renal biopsy 2 years after transplantation revealed infiltration of plasma cells in the renal interstitium, although there was no storiform' fibrosis surrounding these cells. There were also no findings of rejection, BK virus nephropathy, or atypical plasma cells. Immunohistochemical stainings showed a large number of IgG4-positive plasma cells, most of which expressed kappa-type light chains. A CT scan showed a mass at the renal hilum. The serum IgG4 level was high. Based on these findings, the patient was suspected of having IgG4-related kidney disease. Nine months after the biopsy, her serum creatinine level increase to 1.56mg/dL and the dose of methylprednisolone was therefore increased to 16mg/day. Three months after this increase in steroid, a CT scan showed the hilum mass had disappeared. A follow-up biopsy 5 months later showed that infiltration of plasma cells in the renal interstitium had decreased markedly, although focal and segmental severely fibrotic lesions with IgG4-positive plasma cells were observed. Serum IgG4 levels decreased immediately after the increase in steroid dose and remained <100mg/dL despite a reduction in methylprednisolone to 6mg/day. Serum creatinine levels also remained stable at around 1.6mg/dL. To our knowledge, this is the first report of IgG4-positive plasma cell-rich tubulointerstitial nephritis mimicking IgG4-related kidney disease after kidney transplantation.
机译:一名51岁的妇女接受了ABO血型不兼容的肾移植手术。她接受了利妥昔单抗和巴利昔单抗的治疗,并进行了血浆置换以进行诱导治疗,随后施用他克莫司,霉酚酸酯和甲基泼尼松龙作为维持性免疫抑制疗法。计划移植后2年进行的肾脏活检显示,肾间质中浆细胞浸润,尽管这些细胞周围没有星形胶质纤维化。也没有发现排斥反应,BK病毒性肾病或非典型浆细胞的发现。免疫组织化学染色显示大量IgG4阳性浆细胞,其中大多数表达κ型轻链。 CT扫描显示肾门肿块。血清IgG4水平高。基于这些发现,该患者被怀疑患有IgG4相关的肾脏疾病。活检后九个月,她的血清肌酐水平增加到1.56mg / dL,因此甲基泼尼松龙的剂量增加到16mg / d。类固醇增加后三个月,CT扫描显示肺门肿块消失了。 5个月后的随访活检显示,尽管观察到局灶性和节段性IgG4阳性浆细胞严重纤维化病变,但肾间质中浆细胞的浸润明显减少。类固醇剂量增加后,血清IgG4水平立即下降,尽管甲基泼尼松龙降至6mg /天,但仍<100mg / dL。血清肌酐水平也保持稳定在1.6mg / dL左右。据我们所知,这是第一个报道IgG4阳性浆细胞丰富的肾小管间质性肾炎模仿肾脏移植后与IgG4相关的肾脏疾病的报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号